Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) effects of single ascending doses of TGM-312-SC01 in healthy adults and multiple ascending doses in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Timeline

Start

2026-03-03

Primary completion

2028-03

Completion

2028-06

Drugs

Indications